About Applied DNA Sciences (NASDAQ:APDN)
Applied DNA Sciences, Inc. provides biotechnology based security solutions for supply chain security, brand protection, and law enforcement applications in the United States, Europe, Asia, and internationally. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA. It also provides DNAnet, a DNA marker to link evidence and offenders to specific crime scenes; Beacon locked optical markers, which create a protected covert screening tool that can be adapted to packaging, security labels, and high?value assets through inks, varnishes, and coatings; and SigNify IF portable DNA reader that provides real-time authentication of in the field?DNA. In addition, the company offers digitalDNA, a software platform to manage the security of company-marked goods from point of marking to point of authentication or validation to end of life; and DNA Transfer Systems, which offer remote Internet access for real-time monitoring. Further, it provides CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products; and Triathlon PCR systems that allow for the large-scale production of specific DNA sequences. Applied DNA Sciences, Inc. has a cooperative research and development agreement with the U.S. Army Research, Development and Engineering Command's Edgewood Chemical Biological Center; and a collaboration agreement with Colorcon, Inc. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Industry, Sector and Symbol
Industry Miscellaneous business services
Sub-IndustryN/A
SectorIndustrial Products
SymbolNASDAQ:APDN
CUSIPN/A
Phone631-840-8800
Debt
Debt-to-Equity RatioN/A
Current Ratio5.29%
Quick Ratio5.07%
Price-To-Earnings
Trailing P/E Ratio-2.93
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$4.75 million
Price / Sales9.13
Cash FlowN/A
Price / CashN/A
Book Value$0.25 per share
Price / Book5.76
Profitability
EPS (Most Recent Fiscal Year)($0.49)
Net Income$-12,850,000.00
Net Margins-268.66%
Return on Equity-149.68%
Return on Assets-116.76%
Miscellaneous
Employees57
Outstanding Shares30,110,000
Applied DNA Sciences (NASDAQ:APDN) Frequently Asked Questions
What is Applied DNA Sciences' stock symbol?
Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."
How were Applied DNA Sciences' earnings last quarter?
Applied DNA Sciences (NASDAQ:APDN) announced its quarterly earnings results on Thursday, February, 8th. The technology company reported ($0.12) earnings per share (EPS) for the quarter. The technology company had revenue of $0.65 million for the quarter. Applied DNA Sciences had a negative return on equity of 149.68% and a negative net margin of 268.66%. View Applied DNA Sciences' Earnings History.
When is Applied DNA Sciences' next earnings date?
What price target have analysts set for APDN?
1 brokers have issued 12 month target prices for Applied DNA Sciences' shares. Their predictions range from $5.00 to $5.00. On average, they anticipate Applied DNA Sciences' stock price to reach $5.00 in the next year. View Analyst Ratings for Applied DNA Sciences.
Who are some of Applied DNA Sciences' key competitors?
Some companies that are related to Applied DNA Sciences include Capstone Turbine (CPST), CUI Global (CUI), Sharps Compliance (SMED), China Information Technology (CNIT), A.S.V. (ASV), Avingtrans (AVG), Perma-Fix Environmental Services (PESI), Ascent Capital Group (ASCMA), CynergisTek (CTEK), Broadwind Energy (BWEN), Global Power Equipment Gr (GLPW), Supercom (SPCB), Vertex Energy (VTNR), Northbridge Industrial Servi (NBI), Fuel Tech (FTEK), Cemtrex (CETX), H2O Innovation (HEOFF) and Augean (AUG).
Who are Applied DNA Sciences' key executives?
Applied DNA Sciences' management team includes the folowing people:
- Dr. James A. Hayward, Pres, CEO & Chairman (Age 64)
- Ms. Beth M. Jantzen CPA, CFO & Principal Accounting Officer (Age 42)
- Ms. Judith Murrah, Chief Information Officer & Sec. (Age 60)
- Dr. Ming-Hwa Liang, Principal Scientist (Age 56)
- Mr. Bob Miglani, Chief of Bus. Devel.
Has Applied DNA Sciences been receiving favorable news coverage?
Media stories about APDN stock have trended somewhat negative on Thursday, according to Accern Sentiment. The research firm scores the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Applied DNA Sciences earned a media sentiment score of -0.03 on Accern's scale. They also assigned news headlines about the technology company an impact score of 47.01 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of Applied DNA Sciences?
Shares of APDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Applied DNA Sciences' stock price today?
One share of APDN stock can currently be purchased for approximately $1.44.
How big of a company is Applied DNA Sciences?
Applied DNA Sciences has a market capitalization of $43.96 million and generates $4.75 million in revenue each year. The technology company earns $-12,850,000.00 in net income (profit) each year or ($0.49) on an earnings per share basis. Applied DNA Sciences employs 57 workers across the globe.
How can I contact Applied DNA Sciences?
Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The technology company can be reached via phone at 631-840-8800 or via email at [email protected]
MarketBeat Community Rating for Applied DNA Sciences (APDN)
MarketBeat's community ratings are surveys of what our community members think about Applied DNA Sciences and other stocks. Vote "Outperform" if you believe APDN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APDN will underperform the S&P 500 over the long term. You may vote once every thirty days.
Applied DNA Sciences (NASDAQ:APDN) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Applied DNA Sciences in the last 12 months. Their average twelve-month price target is $5.00, suggesting that the stock has a possible upside of 247.22%. The high price target for APDN is $5.00 and the low price target for APDN is $5.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $5.00 | $5.00 | $5.00 | $5.00 |
| Price Target Upside: | 247.22% upside | 228.95% upside | 117.39% upside | 203.03% upside |
Applied DNA Sciences (NASDAQ:APDN) Consensus Price Target History
Applied DNA Sciences (NASDAQ:APDN) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 4/6/2018 | Maxim Group | Set Price Target | Buy | $5.00 | High |  |
(Data available from 4/19/2016 forward)
Applied DNA Sciences (NASDAQ:APDN) Earnings History and Estimates Chart
Applied DNA Sciences (NASDAQ APDN) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/10/2018 | | | | | | | | |
| 2/8/2018 | Q1 2018 | | ($0.12) | | $0.65 million | View | N/A | |
| 12/28/2017 | Q4 2017 | ($0.10) | ($0.10) | | $1.15 million | View | Listen | |
| 8/10/2017 | Q3 2017 | ($0.14) | ($0.10) | $2.18 million | $1.80 million | View | N/A | |
| 5/11/2017 | Q2 2017 | ($0.14) | ($0.13) | $1.25 million | $0.91 million | View | N/A | |
| 2/9/2017 | Q117 | ($0.06) | ($0.16) | $1.66 million | $0.70 million | View | Listen | |
| 12/6/2016 | Q416 | ($0.09) | ($0.10) | $4.98 million | $1.60 million | View | Listen | |
| 8/11/2016 | Q316 | ($0.11) | ($0.14) | $1.47 million | $0.65 million | View | Listen | |
| 5/12/2016 | Q216 | ($0.10) | ($0.14) | $1.60 million | $0.60 million | View | Listen | |
| 2/10/2016 | Q116 | ($0.07) | ($0.13) | $2.04 million | $1.32 million | View | Listen | |
| 12/14/2015 | Q415 | ($0.12) | ($0.02) | $2.09 million | $3.98 million | View | Listen | |
| 8/10/2015 | Q315 | ($0.13) | ($0.08) | $1.45 million | $2.30 million | View | Listen | |
| 5/11/2015 | Q215 | ($0.19) | ($0.11) | $1.30 million | $1.50 million | View | N/A | |
| 2/9/2015 | Q1 2015 | ($0.18) | ($0.25) | $1.00 million | $1.24 million | View | N/A | |
| 12/15/2014 | Q4 2014 | ($0.18) | ($0.16) | $0.95 million | $0.65 million | View | N/A | |
| 2/10/2014 | Q4 | | ($0.01) | $0.85 million | $0.60 million | View | N/A | |
| 2/14/2013 | Q1 2013 | | ($0.60) | | | View | N/A | |
| 8/14/2012 | Q3 2012 | | ($0.12) | | | View | N/A | |
| 5/15/2012 | Q2 2012 | ($0.60) | ($0.18) | | | View | N/A | |
| 12/9/2011 | Q4 2011 | | ($0.60) | | | View | N/A | |
| 8/10/2011 | Q3 2011 | | ($0.36) | | | View | N/A | |
| 5/16/2011 | Q2 2011 | | ($0.42) | | | View | N/A | |
| 2/17/2009 | Q1 2009 | | ($0.60) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Applied DNA Sciences (NASDAQ:APDN) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Applied DNA Sciences (NASDAQ APDN) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 21.41%
Institutional Ownership Percentage: 11.83%
Applied DNA Sciences (NASDAQ APDN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/20/2014 | James A Hayward | CEO | Buy | 76,923 | $3.24 | $249,230.52 | | |
(Data available from 1/1/2013 forward)
Applied DNA Sciences (NASDAQ APDN) News Headlines
| Source: |
|
Applied DNA Sciences (NASDAQ:APDN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Applied DNA Sciences (NASDAQ:APDN) Income Statement, Balance Sheet and Cash Flow Statement
Applied DNA Sciences (NASDAQ APDN) Stock Chart for Thursday, April, 19, 2018
Loading chart…
